agreement: search

OncoMethylome Sciences Announces Licensing and Testing Agreement with Merck KGaA

11 Jun 2008 - OncoMethylome Sciences announced that it has signed a licensing and testing agreement with Merck KGaA of Darmstadt, Germany. Under the terms of the agreement, OncoMethylome will provide MGMT gene promoter methylation testing services for Merck's clinical trial program of cilengitide. As part of the agreement, Merck received a worldwide, non-exclusive license from OncoMethylome to use the results of the OncoMethylome MGMT gene promoter methylation assay for optimizing glioblastoma multiforme (GBM) treatment with cilengitide. Financial terms of the agreement are not disclosed.

RealDealDocs.com - the Online Legal Agreement Source, Releases Multi-Party Master Supply Agreement for Sun Microsystems Inc.

RealDealDocs.com - the Online Legal Agreement Source, Releases Multi-Party Master Supply Agreement for Sun Microsystems Inc.

New Agreement May End the Cable Box

esocid clues us to news that Sony and the National Cable and Telecommunications Association have come to agreement on the way forward for two-way TV without set-top boxes. The actual agreement was not made public, pending review by other members of the Consumer Electronics Association, and as a result the coverage of the agreement is uniformly pretty incoherent. The background is that the NCTA and the CEA submitted competing proposals to the FCC on how to handle two-way, interactive TV services. None of the articles I turned up made clear what the future of the CableCard is to be. This was an interim solution to allow competition in set-top box manufacture, but its adoption has been plagued with problems. "Sony and the cable companies — Comcast, Time Warner Cable, Cox, Charter, Cablevision, and Bright House Networks — agreed to adopt:

MOSAID Signs Patent License Agreement With Fabless Semiconductor Memory Company

MSD) today announced that it has signed three related agreements with a U.S. fabless semiconductor memory company. The agreements consist of a patent portfolio license agreement, a patent transfer agreement, and an exclusive patent sub-licensing agreement.

MOSAID Signs Patent License Agreement With Fabless Semiconductor Memory Company

MSD) today announced that it has signed three related agreements with a U.S. fabless semiconductor memory company. The agreements consist of a patent portfolio license agreement, a patent transfer agreement, and an exclusive patent sub-licensing agreement.

MOSAID Signs Patent License Agreement With Fabless Semiconductor Memory Company

MOSAID Technologies Inc. (TSX: MSD) today announced that it has signed three related agreements with a U.S. fabless semiconductor memory company. The agreements consist of a patent portfolio license agreement, a patent transfer agreement, and an exclusive patent sub-licensing agreement.

MOSAID Signs Patent License Agreement With Fabless Semiconductor Memory Company

OTTAWA, ONTARIO - MOSAID Technologies Inc. (TSX:MSD) today announced that it has signed three related agreements with a U.S. fabless semiconductor memory company. The agreements consist of a patent portfolio license agreement, a patent transfer agreement, and an exclusive patent sub-licensing agreement.

MOSAID Signs Patent License Agreement With Fabless Semiconductor Memory Company

OTTAWA (Marketwire) - MOSAID Technologies Inc. (TSX:MSD) today announced that it has signed three related agreements with a U.S. fabless semiconductor memory company. The agreements consist of a patent portfolio license agreement, a patent transfer agreement, and an exclusive patent sub-licensing agreement.

MOSAID Signs Patent License Agreement With Fabless Semiconductor Memory Company

OTTAWA, ONTARIO -- 06/05/08 -- MOSAID Technologies Inc. (TSX: MSD) today announced that it has signed three related agreements with a U.S. fabless semiconductor memory company. The agreements consist of a patent portfolio license agreement, a patent transfer agreement, and an exclusive patent sub-licensing agreement.

MOSAID Signs Patent License Agreement With Fabless Semiconductor Memory Company

OTTAWA, ONTARIO--(MARKET WIRE)--Jun 5, 2008 -- MOSAID Technologies Inc. (Toronto:MSD.TO - News) today announced that it has signed three related agreements with a U.S. fabless semiconductor memory company. The agreements consist of a patent portfolio license agreement, a patent transfer agreement, and an exclusive patent sub-licensing agreement.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich.--(BUSINESS WIRE)--July 4, 2008--ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Kraig Biocraft Laboratories, Inc. Signs Intellectual Property and Collaborative Research Agreement With the University of Notre Dame and Chemical company Huntsman posts 84 percent 1Q profit drop

City of Industry, CA --(www.USEquityNews.com)-- 05/09/2008 - Synthetics industry alert provided by U.S. Equity News. Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB) announced this morning that the Company has just signed a renewal and expansion of its Collaborative Research and Intellectual Property Agreement with the University of Notre Dame. The agreement provides Kraig with exclusive licensing rights for the products and technology developed pursuant to the collaboration. Additionally, the agreement extends and expands the Company's ongoing research and development program in the University's genetic laboratories. ``The sponsored research program with the University of Notre Dame is a continuing success,'' said Kraig's CEO Kim Thompson, ``and has already resulted in two provisional patent filings.

Universal Music Group (UMG) Expands Digital Music & Video Distribution Agreement With Destiny Media Technologies' Play MPE(R)

Destiny's Proprietary Platform Will Provide Secure Distribution of UMG Pre-Release Digital Media NEW YORK and VANCOUVER, British Columbia, June 6 /PRNewswire/ -- Universal Music Group (UMG), the world's leading music company, and Destiny Media Technologies (OTC Bulletin Board: DSNY) announced today that they have expanded their digital media distribution services agreement to include UMG's affiliates in Canada and Mexico. Under this multi-year agreement, Destiny Media remains the primary, and only company-wide platform, for the global distribution of UMG's pre-release digital media in North America. "This agreement further expands UMG's ability to utilize Play MPE's(R) digital distribution platform which replaces the costly traditional system of delivering promotional CDs using couriers and express mail," stated Vincent Freda, UMG's Execu

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich.--(BUSINESS WIRE)--Jul 4, 2008 - ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Amazon, Borders antitrust case dismissal upheld

Amazon.com and Borders Group won dismissal of an antitrust lawsuit brought by a customer challenging the companies' online marketing agreement. Amazon.com customer Gary Gerlinger didn't pay higher prices for books, and thus suffered no harm, after the retailer took over the unprofitable Borders Web site in 2001, the 9th U.S. Circuit Court of Appeals in San Francisco ruled Tuesday. Gerlinger sued on behalf of all Borders.com customers, saying the companies' agreement that Borders abandon direct online book selling after the takeover violated federal laws prohibiting competitors from dividing markets among themselves. "The prices Gerlinger paid for books purchased from Amazon after the agreement became effective were the same, or even lower, then the prices listed before the defendants entered into the agreement," the court said in upholdin

SPACEHAB Finalizes Agreement with NASA for Use of the International Space Station as a National Laboratory

HOUSTON - (Business Wire) SPACEHAB, Inc. (NASDAQ:SPAB) today announced that the company has finalized a Space Act Agreement with the National Aeronautics and Space Administration (NASA) for use of the International Space Station (ISS), a designated U.S. National Laboratory, for research, development and industrial processing purposes. This agreement marks the beginning of SPACEHAB

Anti-Counterfeiting Trade Agreement

SpaceAdmiral writes "The Canadian government is secretly negotiating to join the US and the EU in an Anti-Counterfeiting Trade Agreement. The agreement would give border guards the power to search iPods and cellphones for illegal downloads, as well as to force ISPs to hand over customer information without a warrant. David Fewer, staff counsel at the University of Ottawa's Canadian Internet Policy and Public Interest Clinic, characterizes ACTA this way: 'If Hollywood could order intellectual property laws for Christmas what would they look like? This is pretty close.'"

ENCS: Enters Patent Licensing Agreement with Energy America Geothermal

Encore Energy Systems (ENCS) announced it entered into a patent license agreement with Texas LLC, Energy America Geothermal. Under the terms of the Agreement, Encore Energy will license its patent to Energy America Geothermal. The Company will receive a royalty from installed systems based on total installation value.

BI Incorporated Announces Agreement With AnyTransactions, Inc., for roboCUFF Voice Supervision Servi

Boulder, CO (PRWEB) June 13, 2008 -- BI Incorporated, a leading national provider of offender supervision and reentry services, announced today a multi-year licensing agreement with AnyTransactions, Inc., makers of roboCUFF Voice Supervision Services. Under terms of the agreement, BI will market, sell and support the roboCUFF products beginning in June. These products will add to BI's extensive continuum of technologies used by correctional and pre-trial service agencies to manage offenders released to community supervision.

Cree (CREE) Reaches Patent Agreement with Toyoda Gosei

Cree (Nasdaq: CREE) today announced that it has entered into an agreement with Toyoda Gosei providing the companies with access to each other's patented LED chip and packaged LED technology. Cree and Toyoda Gosei both hold broad and substantial optoelectronic patent portfolios. The agreement will make it easier for both companies to develop and manufacture LED products without concern for the other's patents.

Search took 0.07 seconds.